116 related articles for article (PubMed ID: 17186508)
1. Low gammaglobulin subclass 2 levels in paediatric cystic fibrosis patients followed over a 2-year period.
Garside JP; Kerrin DP; Brownlee KG; Gooi HC; Taylor JM; Conway SP
Pediatr Pulmonol; 2007 Feb; 42(2):125-30. PubMed ID: 17186508
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
[TBL] [Abstract][Full Text] [Related]
3. [Significance of IgG serum levels in cystic fibrosis].
Vázquez Cordero C; Sánchez Obregón M; Molinuevo Alvaro J; Larrea Rementería F; Vitoria Cormenzana JC; Sojo Aguirre A
An Esp Pediatr; 1988 Apr; 28(4):321-4. PubMed ID: 3400941
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin and IgG subclass levels in a regional pediatric cystic fibrosis clinic.
Garside JP; Kerrin DP; Brownlee KG; Gooi HC; Taylor JM; Conway SP
Pediatr Pulmonol; 2005 Feb; 39(2):135-40. PubMed ID: 15633199
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
[TBL] [Abstract][Full Text] [Related]
9. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
[TBL] [Abstract][Full Text] [Related]
10. Expression of idiotypic antibodies-1 and -2 and breastfeeding in relation to antibody levels against Haemophilus influenzae type B in children.
Silfverdal SA; Bodin L; Ulanova M; Hahn-Zoric M; Hanson LA; Olcén P
Scand J Immunol; 2006 May; 63(5):371-5. PubMed ID: 16640661
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
[TBL] [Abstract][Full Text] [Related]
13. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency.
Kutukculer N; Karaca NE; Demircioglu O; Aksu G
Pediatr Allergy Immunol; 2007 Mar; 18(2):167-73. PubMed ID: 17338791
[TBL] [Abstract][Full Text] [Related]
14. [Study of IGG subgroups as prognosis markers in cystic fibrosis].
Visca A; Castello M; Castello D
Minerva Pediatr; 1994 May; 46(5):245-9. PubMed ID: 8090143
[TBL] [Abstract][Full Text] [Related]
15. Differential cytokine profile in children with cystic fibrosis.
Brazova J; Sediva A; Pospisilova D; Vavrova V; Pohunek P; Macek M; Bartunkova J; Lauschmann H
Clin Immunol; 2005 May; 115(2):210-5. PubMed ID: 15885645
[TBL] [Abstract][Full Text] [Related]
16. IgG subclass responses to Pseudomonas aeruginosa a- and b-type flagellins in patients with cystic fibrosis: a prospective study.
Lagacé J; Péloquin L; Kermani P; Montie TC
J Med Microbiol; 1995 Oct; 43(4):270-6. PubMed ID: 7562988
[TBL] [Abstract][Full Text] [Related]
17. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pressler T
APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
[No Abstract] [Full Text] [Related]
18. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
Clin Exp Immunol; 1990 Sep; 81(3):428-34. PubMed ID: 2118845
[TBL] [Abstract][Full Text] [Related]
19. Increased IgG2 and IgG3 concentration is associated with advanced Pseudomonas aeruginosa infection and poor pulmonary function in cystic fibrosis.
Pressler T; Mansa B; Jensen T; Pedersen SS; Høiby N; Koch C
Acta Paediatr Scand; 1988 Jul; 77(4):576-82. PubMed ID: 3134794
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N
Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
